• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4660768)   Today's Articles (1072)   Subscriber (51488)
Download
Number Citation Analysis
1
Thabault M, Fernandes-Gomes C, Huot AL, Francheteau M, Balbous-Gautier A, Fernagut PO, Galvan L. Dysfunction of striatal parvalbumin interneurons drives motor stereotypies in Cntnap2-/- mouse model of autism spectrum disorders. PNAS NEXUS 2024;3:pgae132. [PMID: 38617583 PMCID: PMC11010650 DOI: 10.1093/pnasnexus/pgae132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Accepted: 03/18/2024] [Indexed: 04/16/2024]
2
Estrada-Sánchez AM, Rebec GV, Galvan L. Editorial: New insight into Huntington's disease: From neuropathology to possible therapeutic targets. Front Neurosci 2023;17:1138712. [PMID: 36816128 PMCID: PMC9933495 DOI: 10.3389/fnins.2023.1138712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2023] [Accepted: 01/20/2023] [Indexed: 02/05/2023]  Open
3
Thabault M, Turpin V, Balado É, Fernandes-Gomes C, Huot AL, Cantereau A, Fernagut PO, Jaber M, Galvan L. Age-related behavioural and striatal dysfunctions in Shank3ΔC/ΔC mouse model of autism spectrum disorder. Eur J Neurosci 2023;57:607-618. [PMID: 36656446 DOI: 10.1111/ejn.15919] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Revised: 12/13/2022] [Accepted: 01/13/2023] [Indexed: 01/20/2023]
4
Thabault M, Turpin V, Maisterrena A, Jaber M, Egloff M, Galvan L. Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models. Int J Mol Sci 2022;23:2294. [PMID: 35216408 PMCID: PMC8874522 DOI: 10.3390/ijms23042294] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 02/07/2022] [Accepted: 02/08/2022] [Indexed: 02/06/2023]  Open
5
Matas E, Maisterrena A, Thabault M, Balado E, Francheteau M, Balbous A, Galvan L, Jaber M. Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model. Mol Autism 2021;12:2. [PMID: 33468258 PMCID: PMC7814442 DOI: 10.1186/s13229-020-00412-8] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Accepted: 12/29/2020] [Indexed: 11/10/2022]  Open
6
Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, Petit F, Jan C, Jarrige M, Dufour N, Bonvento G, Humbert S, Saudou F, Hantraye P, Merienne K, Bemelmans AP, Perrier AL, Déglon N, Brouillet E. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain 2019. [PMID: 29534157 PMCID: PMC5917821 DOI: 10.1093/brain/awy057] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
7
Holley SM, Galvan L, Kamdjou T, Dong A, Levine MS, Cepeda C. Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease Mice. Front Synaptic Neurosci 2019;11:14. [PMID: 31139071 PMCID: PMC6527892 DOI: 10.3389/fnsyn.2019.00014] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2019] [Accepted: 04/23/2019] [Indexed: 01/01/2023]  Open
8
Holley SM, Galvan L, Kamdjou T, Cepeda C, Levine MS. Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease. Eur J Neurosci 2018;49:79-93. [PMID: 30472747 DOI: 10.1111/ejn.14283] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Revised: 11/01/2018] [Accepted: 11/13/2018] [Indexed: 01/01/2023]
9
Galvan L, André VM, Wang EA, Cepeda C, Levine MS. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. J Huntingtons Dis 2016;1:17-25. [PMID: 25063187 DOI: 10.3233/jhd-2012-120009] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
10
Boussicault L, Alves S, Lamazière A, Planques A, Heck N, Moumné L, Despres G, Bolte S, Hu A, Pagès C, Galvan L, Piguet F, Aubourg P, Cartier N, Caboche J, Betuing S. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. Brain 2016;139:953-70. [PMID: 26912634 PMCID: PMC4766376 DOI: 10.1093/brain/awv384] [Citation(s) in RCA: 129] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Accepted: 11/04/2015] [Indexed: 11/22/2022]  Open
11
Berg JM, Lee C, Chen L, Galvan L, Cepeda C, Chen JY, Peñagarikano O, Stein JL, Li A, Oguro-Ando A, Miller JA, Vashisht AA, Starks ME, Kite EP, Tam E, Gdalyahu A, Al-Sharif NB, Burkett ZD, White SA, Fears SC, Levine MS, Wohlschlegel JA, Geschwind DH. JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron 2015;88:1173-1191. [PMID: 26627310 DOI: 10.1016/j.neuron.2015.10.031] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Revised: 09/02/2015] [Accepted: 10/15/2015] [Indexed: 11/18/2022]
12
Francelle L, Galvan L, Gaillard MC, Guillermier M, Houitte D, Bonvento G, Petit F, Jan C, Dufour N, Hantraye P, Elalouf JM, De Chaldée M, Déglon N, Brouillet E. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Hum Mol Genet 2014;24:1563-73. [PMID: 25398949 PMCID: PMC4381754 DOI: 10.1093/hmg/ddu571] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]  Open
13
Francelle L, Galvan L, Brouillet E. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Front Cell Neurosci 2014;8:295. [PMID: 25309327 PMCID: PMC4176035 DOI: 10.3389/fncel.2014.00295] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Accepted: 09/03/2014] [Indexed: 01/01/2023]  Open
14
Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 2013;22:3869-82. [PMID: 23720495 PMCID: PMC3766181 DOI: 10.1093/hmg/ddt242] [Citation(s) in RCA: 85] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
15
Chen JY, Wang E, Galvan L, Huynh M, Joshi P, Cepeda C, Levine MS. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's Disease. PLOS CURRENTS 2013;5. [PMID: 23437422 PMCID: PMC3574864 DOI: 10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
16
Olmo M, Galvan L, Capdevila J, Serna C, Mangues I, Schoenenberger JA. Management by objectives and its impact on specialist prescription quality at discharge and in external consultations. FARMACIA HOSPITALARIA 2011;35:58-63. [PMID: 20678949 DOI: 10.1016/j.farma.2010.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2010] [Accepted: 04/26/2010] [Indexed: 10/19/2022]  Open
17
Damiano M, Galvan L, Déglon N, Brouillet E. Mitochondria in Huntington's disease. Biochim Biophys Acta Mol Basis Dis 2010;1802:52-61. [DOI: 10.1016/j.bbadis.2009.07.012] [Citation(s) in RCA: 201] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2009] [Revised: 07/31/2009] [Accepted: 07/31/2009] [Indexed: 11/16/2022]
18
Galvan L, Brouillet E. Rhes, a protein with selective expression in the striatum, plays a major role in Huntington’s disease pathogenesis. FUTURE NEUROLOGY 2009. [DOI: 10.2217/fnl.09.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
19
Espallergues J, Galvan L, Sabatier F, Rana-Poussine V, Maurice T, Chatonnet A. Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugs. Behav Brain Res 2009;206:263-73. [PMID: 19766675 DOI: 10.1016/j.bbr.2009.09.024] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2009] [Revised: 09/09/2009] [Accepted: 09/14/2009] [Indexed: 12/24/2022]
20
Galvan L. Effects of heparin on wound healing. J Wound Ostomy Continence Nurs 1996;23:224-6. [PMID: 8900676 DOI: 10.1016/s1071-5754(96)90095-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
21
Galvan L, Evans JE, Huang CH, Prestayko A, Wu B, Crooke ST. Inhibition of PM-2 DNA degradation by a human serum protein. Cancer Res 1982;42:1555-61. [PMID: 6174227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
22
Galvan L, Evans JE, Comis RL, Gottlieb A, Gyorkey F, Lane M, Prestayko AW, Crooke ST. Detection of a serum DNA-binding protein associated with cancer. Cancer Res 1982;42:1562-6. [PMID: 6174228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
23
Galvan L, Huang CH, Prestayko AW, Stout JT, Evans JE, Crooke ST. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res 1981;41:5103-6. [PMID: 6171347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
24
Huang CH, Galvan L, Crooke ST. Interactions of bleomycin analogues with deoxyribonucleic acid and metal ions studied by fluorescence quenching. Biochemistry 1980;19:1761-7. [PMID: 6155142 DOI: 10.1021/bi00550a006] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
25
Galvan L, Strong JE, Crooke ST. Use of PM-2 DNA degradation as a pharmacokinetic assay for bleomycin. Cancer Res 1979;39:3948-51. [PMID: 89893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
PrevPage 1 of 2 12Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel